Debora Marchiori
Overview
Explore the profile of Debora Marchiori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cocci A, Pezzoli M, Bianco F, Blefari F, Bove P, Cornud F, et al.
Asian J Urol
. 2024 Apr;
11(2):271-279.
PMID: 38680587
Objective: To evaluate transperineal laser ablation (TPLA) with Echolaser® (Echolaser® TPLA, Elesta S.p.A., Calenzano, Italy) as a treatment for benign prostatic hyperplasia (BPH) and prostate cancer (PCa) using the Delphi...
2.
Marchiori D, Zanello P
In Vivo
. 2017 Sep;
31(5):931-936.
PMID: 28882961
Background/aim: Breast cancer survivors in adjuvant therapy, frequently experience the estrogen deficiency with genitourinary symptoms mostly represented by recurrent bacterial cystitis. The objective of the present study was to evaluate...
3.
De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B, et al.
Tumori
. 2014 Feb;
99(6):637-49.
PMID: 24503785
Aims And Background: The diagnostic and therapeutic approach to prostate cancer has evolved rapidly in last decades. Young professionals need an update about these recent developments in order to improve...
4.
Bertaccini A, Marchiori D
Urologia
. 2012 Oct;
79(3):197-9.
PMID: 23032635
Hormonal therapy is one of the treatment options for prostate cancer patients. There are many hormonal treatments modality to block the testosterone effect on prostate cancer cell proliferation. Degarelix is...
5.
Testoni N, Speciale N, Bertaccini A, Marchiori D, Fiorentino M, Manferrari F, et al.
Arch Ital Urol Androl
. 2011 Feb;
82(4):238-41.
PMID: 21341571
Objective: Prostate carcinoma (PCa) is one of the most frequent neoplasms, with more than 110.000 new cases/year in Europe. As PCa is not clearly demonstrable at transrectal ultrasound (TRUS), guidelines...
6.
Marchiori D, Bertaccini A, Manferrari F, Ferri C, Martorana G
Anticancer Res
. 2010 Mar;
30(2):553-6.
PMID: 20332469
Purpose: radical prostatectomy (RP) is affected by urinary incontinence (UI) that, even if temporary, can severely impact patients quality of life. We investigated if a post surgery tutored and personal...
7.
Bertaccini A, Pernetti R, Marchiori D, Pagotto U, Palladoro F, Palmieri F, et al.
Anticancer Res
. 2009 May;
29(4):1345-8.
PMID: 19414385
Background: Ghrelin is a natural growth hormone segretagogue (GHS), involved in the biology of a number of diseases such as lung cancer and prostate cancer. The aim of this study...
8.
De Stefano R, Carluccio R, Zanni E, Marchiori D, Cicchetti G, Bertaccini A, et al.
Anticancer Res
. 2009 Apr;
29(2):473-6.
PMID: 19331189
Literature reports intra-thyroid involvement of renal cell carcinoma (RCC) as a very rare and late event after kidney cancer diagnosis. Nevertheless, it must be investigated and differentiated from primary thyroid...
9.
Bertaccini A, Franceschelli A, Schiavina R, Marchiori D, Baccos A, Pernetti R, et al.
Anticancer Res
. 2008 Jul;
28(3B):1883-6.
PMID: 18630475
Background: This study evaluated the accuracy of a new echographic method named RULES (radiofrequency ultrasonic local estimators) in the diagnosis of prostate cancer. Patients And Methods: A double-blind prospective study...
10.
Bertaccini A, Marchiori D, Cricca A, Garofalo M, Giovannini C, Manferrari F, et al.
Anticancer Res
. 2008 May;
28(2B):1369-72.
PMID: 18505081
Small and large cell neuroendocrine carcinomas of the urinary bladder are rare and usually coexist with urothelial carcinoma in elderly patients. Here we report the clinical case of a young...